What Is Prior Authorization and Why It’s Slowing Down Your Practice In 2026
Prior authorization is one of the most disruptive forces in day-to-day clinical operations right now, and it has gotten measurably worse over the past few years. More services require it, documentation standards have tightened, and denial-first workflows have become common practice across commercial payers and Medicare Advantage plans. If your team feels like it is spending more time managing insurance logistics than actually delivering care, this article will explain exactly why, and what you can realistically do about it. What Is Prior Authorization? Prior authorization (PA) is an insurer’s requirement that a provider obtain approval before a service, medication, imaging study, or procedure will be covered. Without that approval in place, the payer can deny the claim outright, regardless of how medically appropriate the care was. PA applies across a wide range of services: specialty medications, advanced imaging like MRI and CT, elective and semi-elective procedures, durable medical equipment, post-acute care, and in some cases labs and therapy services. It is used by commercial health plans, Medicare Advantage plans, and Medicaid managed care organizations, though the specific rules vary significantly by plan and by state. A few quick clarifications worth making: prior authorization is not the same as a referral. A referral routes a patient to another provider. Prior authorization approves a specific service for coverage. Precertification is a term some payers use interchangeably with PA, though it sometimes refers specifically to inpatient admissions. These terms overlap enough to cause confusion at the front desk, which is part of the problem. Why It Exists (and Where It Falls Apart) From the payer’s perspective, prior authorization is a utilization management tool. The stated goals are straightforward: contain costs, discourage low-value care, enforce clinical guideline adherence, and reduce waste. In theory, PA creates checkpoints that catch unnecessary procedures, ensure step therapy protocols are followed for medications, and flag high-cost outlier cases for review. In practice, the logic breaks down quickly. The criteria used to evaluate requests are often outdated, built around population averages rather than individual clinical presentations, and inconsistently applied across reviewers. A patient with a complicated history who genuinely needs the treatment still has to clear the same administrative hurdles as a potentially inappropriate case. The PA process does not distinguish between the two, at least not without significant effort from your team. Even when the authorization is eventually approved, the time, paperwork, and follow-up required to get there is an operational cost your practice absorbs entirely. How the Process Actually Works The PA process has several distinct steps, and friction can enter at any one of them. First, your team needs to confirm whether PA is even required. This sounds simple but is not. The same CPT code can have different PA requirements depending on the place of service, the patient’s specific plan, the diagnosis, or the provider type. Payer portals are inconsistent. Policies update without clear notice. Once you confirm PA is required, you submit the request. That means pulling the right CPT and ICD-10 codes, attaching supporting clinical documentation, noting prior treatments tried, and using the payer’s preferred submission channel, which might be a portal, a phone call, or a fax depending on the plan. From there, the request goes into clinical review. Simple requests might clear automated edits. Others go to a nurse reviewer, and some escalate to a physician reviewer. The decision comes back as approved, pended (meaning more information is needed), or denied. An approval means you document the authorization number, confirm the validity window, and schedule the service. A pended decision sends you back to track down whatever the reviewer says is missing and resubmit. Denials are the most disruptive outcome, putting you on the path to a peer-to-peer review request, a formal appeal, or in some cases an external review process, each with its own timeline and paperwork requirements. Why It Slows Practices Down The slowdown is not caused by any single thing. It is the accumulation of small friction points across every step. Eligibility Uncertainty At Intake Plans change. Benefit details are not always clear at the time of scheduling. Your staff confirms PA requirements, and then the patient’s coverage switches, or the plan updates its policy, and the process starts over. Incomplete First Submissions Even when your care is entirely appropriate, a missing line in the chart note, an undocumented treatment trial, or a gap in the symptom timeline can trigger a pend. The information usually exists somewhere in the chart, just not in the format or location the payer’s reviewer is looking for. Denials As A First Response Some payers routinely deny certain service types on the first submission, expecting the practice to escalate via peer-to-peer. This is not an edge case. It is a predictable pattern for specific service lines and payers. The problem is that peer-to-peer reviews require physician time, often during clinic hours, with reviewers who may not share the same specialty and who apply criteria that shift depending on who picks up the phone. When you add these bottlenecks together across your entire authorization volume, the result is delayed procedures, lost OR and imaging slots, disrupted schedules, frustrated patients, and clinical staff spending hours on tasks that have nothing to do with clinical care. Where It Hits Hardest Certain service areas generate a disproportionate share of PA burden. Advanced imaging is one of the heaviest, with MRI and CT requests often requiring documentation of symptom duration, failed conservative treatment, and specific clinical indicators. Specialty medications carry some of the most complex requirements, including step therapy documentation, quantity limit justifications, and frequent reauthorizations. Surgical procedures often require pre-op clinical packages and site-of-care justifications. DME and post-acute services have their own documentation standards and recertification cycles on top of initial authorizations. In 2026, a few trends are making this worse. Payer-side automation has increased, which sounds like it should help, but algorithm-based edits are flagging more requests for human review when documentation does not match exact phrasing criteria. Reauthorization requirements for chronic therapies have become more